Bill Texts: IL HB2531 | 2017-2018 | 100th General Assembly

Bill Title: Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately.

Spectrum: Partisan Bill (Republican 3-0)

Status: (Passed) 2017-08-11 - Public Act . . . . . . . . . 100-0065 [HB2531 Detail]

Bill Drafts

RevisionDateFormatSourceView
Chaptered2017-08-14HTML/TextLinkView
Enrolled2017-05-19HTML/TextLinkView
Engrossed2017-03-13HTML/TextLinkView
Introduced2017-02-08HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for Illinois HB2531

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for Illinois HB2531 currently on file.

Social Comments on IL HB2531

feedback